Log in

i2o Therapeutics
Andrew Young

Andrew Young

Chief Scientific And Medical Officer at i2o Therapeutics

About

Links

Previous companies

Timeline

Chief Scientific And Medical Officer
November, 2023 - present

A panel showing how The Org can help with contacting the right person.

Related people

Ivan Horak
Chief Scientific and Medical Officer at Symphogen
Stefan-Alexander Albrecht
Chief Scientific And Medical Officer. Managing Director Merz Therapeutics at Merz Pharma
Anna Berkenblit
Chief Scientific And Medical Officer at Pancreatic Cancer Action Network